Sites / Minneapolis Heart Institute Foundation
Is this you?

Request access for Minneapolis Heart Institute Foundation with your @mhif.org work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Minneapolis Heart Institute Foundation

Unclaimed profile

Academic Network · Minneapolis, MN · ~Unknown sites

Intera lens
ICP 3Lift (cardio sample) 0.67Recruit soph 0.14
Quality Scorecard (1–100)
Overall80Recruit60Ops88Sponsor86Ther89

Performance (observed)

Historical trials
473
Completed
268
Terminated/Withdrawn
31
Completion rate
90%
Active now
159
Phase 2
108
Phase 3
176
Realized enrollment
573,971
First study year
1988
Years active
38
Match confidence
high
Enrollment velocity (inf)
15,104

Therapeutic

Areas
Cardiovascular/Vascular research (coronary artery disease, heart failure, heart rhythm, valve disease, vascular/endovascular, women's heart health)
Specialties
Cardiovascular, Heart disease, Women's heart health
Breadth (conditions)
935
Languages
English + Spanish (detected)
States
MN (Minneapolis)

Recruitment (web observed)

Trial Finder
Yes
SEO
Y
Capability notes
43 active clinical studies; 350+ patients enrolled; cardiovascular specialist network; physician-led research

Relationships

Sponsors
Children's Oncology Group; National Cancer Institute (NCI); Abbott Medical Devices; Alliance for Clinical Trials in Oncology; Minneapolis Heart Institute Foundation; SWOG Cancer Research Network
CROs
CroiValve Limited; Rho Federal Systems Division, Inc.; Shanghai MicroPort Medical (Group) Co., Ltd.
Owner / parent
Non-profit foundation (45-year history)
Recent hiring
Y

Capacity & people

Investigators
—
Coordinators
—
CEO
Kristine Fortman, PhD
VP Clinical Ops
Lisa Tindell (Vice President, Clinical Research Operations)
VP Site Ops
Unknown
VP Recruitment
Ross Garberich, MS, MBA (Vice President, Scientific Services)

Tech & DCT

EHR
Y
eSource
Yes
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y

Notes

Specialty academic research foundation focused on cardiovascular research. Strong scientific reputation and publications (300+). However, limited to cardiology/vascular specialty. Does not advertise patient recruitment; emphasis is on scientific excellence. Established but academic/non-profit procurement model. Geographic limitation (Minneapolis). Low ICP fit: specialty-constrained, not recruitment-focused business model. [Validated: 5 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.78Liftability 0.67Overall80

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.